Hiroaki Shimizu

Prof. Dr. Hiroaki Shimizu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HNHiroyuki Nojima
Hiroyuki Nojima
HSHiroaki Shimizu
Hiroaki Shimizu
TMTakashi Murakami
Takashi Murakami
KSKiyohiko Shuto
Kiyohiko Shuto
KKKeiji Koda
Keiji Koda
The sphingolipid metabolic pathway, an important signaling pathway, plays a crucial role in various physiological processes including cell proliferation, survival, apoptosis, and immune regulation. The liver has the unique ability to regenerate using bioactive lipid mediators involving multiple sphingolipids, including ceramide and sphingosine 1-phosphate (S1P). Dysregulation of the balance between sphingomyelin, ceramide, and S1P has been implicated in the regulation of liver regeneration and diseases, including liver fibrosis and hepatocellular carcinoma (HCC). Understanding and modulating this balance may have therapeutic implications for tumor proliferation, progression, and metastasis in HCC. For cancer therapy, several inhibitors and activators of sphingolipid signaling, including ABC294640, SKI-II, and FTY720, have been discussed. Here, we elucidate the critical roles of the sphingolipid pathway in the regulation of liver regeneration, fibrosis, and HCC. Regulation of sphingolipids and their corresponding enzymes may considerably influence new insights into therapies for various liver disorders and diseases.

29 November 2018 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
IHIsamu Hosokawa
Isamu Hosokawa
MOMasayuki Ohtsuka
Masayuki Ohtsuka
HYHideyuki Yoshitomi
Hideyuki Yoshitomi
KFKatsunori Furukawa
Katsunori Furukawa
MMMasaru Miyazaki
Masaru Miyazaki
HSHiroaki Shimizu
Hiroaki Shimizu

21 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
KSKiyohiko Shuto
Kiyohiko Shuto
YNYoshihiro Nabeya
Yoshihiro Nabeya
MMMikito Mori
Mikito Mori
MYMasato Yamazaki
Masato Yamazaki
CKChihiro Kosugi
Chihiro Kosugi
KKKeiji Koda
Keiji Koda
Background: Postoperative changes in body composition (BC) have not been clearly defined. The aim of this study was to clarify the impact of postoperative comprehensive changes in BC on long-term prognosis in gastric cancer (GC) patients. Methods: A total of 366 GC patients who underwent radical gastrectomy were included. Postoperative changes in skeletal muscle volume, body fat volume, and skeletal muscle density were investigated at six months postoperatively using computed tomography and evaluated their association with long-term survival. Results: Patients with decreased muscle volume, decreased fat volume, and increased muscle density had a poor prognosis, respectively. When the risk scores based on these three BC parameters were applied, patients were classified from score 0 to 4, with survival rate declining as the scores improved: score 0, interim 5-year overall survival 94%; score 1, 82%; score 2, 73%; score 3, 56%; and score 4, 20%. BC change (score > 2) was an independent poor prognosticator (HR, 3.086; p < 0.001). Preoperative myosteatosis, high Charlson comorbidity, and total gastrectomy were identified as significant independent risk factors for BC change. Conclusions: Each of postoperative skeletal muscle loss, body fat loss, and muscle hyperdensity negatively affected prognosis of GC patients after surgery, and the BC risk scoring assessment well predicted the prognosis of postoperative patients with GC.

2 May 2018 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
HSHiroaki Shimizu
Hiroaki Shimizu
TITakao Itoi
Takao Itoi
KSKeiji Sano
Keiji Sano

9 March 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
IHIsamu Hosokawa
Isamu Hosokawa
HSHiroaki Shimizu
Hiroaki Shimizu
MOMasayuki Ohtsuka
Masayuki Ohtsuka
MMMasaru Miyazaki
Masaru Miyazaki

22 April 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
IHIsamu Hosokawa
Isamu Hosokawa
HSHiroaki Shimizu
Hiroaki Shimizu